References
- Waldvogel FA. Staphylococcus aureus (including toxic shock syndrome). In Mandell, Douglas and Bennett’s. Principles and practice of infectious diseases. Fourth edition, 1995: 1754–1776.
- Archer GL. Staphylococcus epidermidis and other coagulase-negative staphylococci. In Mandell, Douglas and Bennett’s. Principles and practice of infectious diseases. Fourth edition, 1995: 1777–1784.
- Gold HS, Moellering Jr RC. Antimicrobial drug resistance. N Engl J Med 1996; 335:1445–53.
- Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguzi T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40: 135–136.
- Centers for Disease Control and Prevention. Staphylococcus aureus with reduced susceptibility to vancomycin-United States. Morbid Mortal Wkly Rep 1997; 46: 765–766.
- Ploy MC, Greland C, Martin C, de Lumley L, Denis F. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital. Lancet 1998; 351: 1212.
- Siradzki K, Roberts RB, Harber SW, Tomasz A. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N Engl J Med 1999; 340: 517–523.
- Hiramatsu K, Aritaka N, Hanki H et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997; 350: 1670–73.
- Ariza J, Pujol M, Cabo J, et al. Vancomycin in surgical infections due to methicillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin. Lancet 1999; 353: 1587–1588.
- Marchese A, Balistreri G, Tonoli E, Debbia EA, Schito GC. Heterogeneous vancomycin resistance in methicillin-resistant Staphylococcus aureus isolated in a large Italian hospital. J Clin Microbiol 2000; 38: 866–869.
- Kaatz GW, Seo SM, Dorman NJ, Lerner SA. Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis. J Infect Dis 1990; 162: 103–108.
- Marchese A, Debbia EA, Bacca D, Balistreri G, Musolino B, Schito GC. Multidrug-resistant Gram-positive pathogens. Drugs 1997; 54, Suppl 6: 11–20.
- Roberts RB, de Lencastre A, Eisner W, et al and the MRSA Collaborative Study Group. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in 12 New York hospitals. J Infect Dis 1998; 178: 164–71.
- Mainardi J, Shales DM, Goering RV, Shales JH, Acar JF, Goldstein FW. Decreased teicoplanin susceptibility of methicillin-resistant strains of Staphylococcus aureus. J Infect Dis 1995; 171: 1646–50.
- Moreira B, Boyle-Vara S, deJonge BLM, Daum RS. Increased production of penicillin-binding protein 2, increased detection of other penicillin-binding proteins and decreased coagulase activity associated with glycopeptide resistance in Staphylococcus aureus. Antimicrob Agents Chemother 1997; 41: 1788–1793.
- Swenson JM, Hindler JA, Peterson LR. Special tests for detecting antibacterial resistance. In Murray et al., Eds. Manual of Clinical Microbiology, Sixth Ed. Washington, DC: ASM Press, 1995: 1356–1367.
- Tenover FC. VRSA, VISA, and GISA: the dilemma behind the name game. Clin Microbiol Lett 2000; 22: 49–53.
- Marchese A; Schito GC. Osservatorio epidemiologico italiano per il monitoraggio delle resistenze agli antibiotici nei patogeni respiratori comunitari 1997-1999: significato per la pratica clinica. GIMMOC 2000; 4: 51–58.
- Cipriani P, Debbia EA, Gesu GP, et al. Indagine AMCLI sulla prevalenza in un giorno indice di resistenze agli antibiotici Escherichia coli, Pseudomonas aeruginosa e Staphylococcus aureus. Microbiol Med 1995; 10: 133–137.
- Fontana R, Cornaglia G. Sensibilità agli antibiotici di ceppi di Enterobacteriaceae e Staphylococcus aureus isolati dalle vie respiratorie nel 1997 e nel 1998. Microbiol Med 1999; 14 (Suppl. I): 38–45.